π¬ Drug Side Effect Linked to Better Cancer Survival
Enfortumab Vedotin-induced skin toxicity has been observed in patients with urothelial cancer. This finding was reported by Cancer Therapy Advisor regarding cancer treatment outcomes. The data suggests that this side effect is actually correlated with improved survival rates for the patients. This suggests a complex relationship between adverse drug reactions and therapeutic benefit in cancer care. Further research is needed to fully understand this surprising connection.